NCT00309205View on ClinicalTrials.gov

A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in Belgium

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 31, 2005

Conditions
HIV InfectionsHIV-1
Interventions
DRUG

dapivirine (TMC120) vaginal gel

Trial Locations (1)

2060

SGS Biopharma - Research Unit Stuivenberg, Antwerp

All Listed Sponsors
lead

International Partnership for Microbicides, Inc.

INDUSTRY

NCT00309205 - A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in Belgium | Biotech Hunter | Biotech Hunter